Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/14347
Full metadata record
DC FieldValueLanguage
dc.contributor.authorWangchuk P.
dc.contributor.authorKeller P.A.
dc.contributor.authorPyne S.G.
dc.contributor.authorSastraruji T.
dc.contributor.authorTaweechotipatr M.
dc.contributor.authorRattanajak R.
dc.contributor.authorTonsomboon A.
dc.contributor.authorKamchonwongpaisan S.
dc.date.accessioned2021-04-05T03:34:19Z-
dc.date.available2021-04-05T03:34:19Z-
dc.date.issued2012
dc.identifier.issn1934578X
dc.identifier.other2-s2.0-84861505544
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/14347-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84861505544&doi=10.1177%2f1934578x1200700507&partnerID=40&md5=32ca02c41f971064f9320f03e533e056
dc.description.abstractThe chemical constituents and biological activities of Corydalis crispa (Fumariaceae) were investigated for the first time. The phytochemical study resulted in the isolation of nine known isoquinoline alkaloids: protopine (1), 13-oxoprotopine (2), 13-oxocryptopine (3), stylopine (4), coreximine (5), rheagenine (6), ochrobirine (7), sibiricine (8) and bicuculline (9), with complete NMR data for 2 and 3 provided here for the first time. Crude extracts exhibited significant anti-inflammatory (p<0.01) activity against TNF-α production in LPS activated THP-1 cells. The acetylcholinesterase inhibitory activity of compounds 2, 4 and 7 and the antiplasmodial activity of compound 5 against P. falciparum strains TM4/8.2 and K1CB1 (multidrug resistant strain) are reported here for the first time. Stylopine (4) did not show antimalarial activity against the K1CB1 strain in contrast to a previous report. This study generated a scientific basis for the use of this plant in Bhutanese traditional medicine, either individually or in combination with other medicinal ingredients to treat a broad range of disorders. This study also identified compound 5 as potential new antimalarial lead compound.
dc.subject13 oxocryptopine
dc.subject13 oxoprotopine
dc.subjectamoxicillin
dc.subjectamphotericin B
dc.subjectantibiotic agent
dc.subjectantiflagellate agent
dc.subjectantifungal agent
dc.subjectantiinflammatory agent
dc.subjectantimalarial agent
dc.subjectantitrypanosomal agent
dc.subjectbicuculline
dc.subjectchloroquine
dc.subjectcoreximine
dc.subjectCorydalis crispa extract
dc.subjectcycloguanil
dc.subjectdexamethasone
dc.subjectgalantamine
dc.subjectochrobirine
dc.subjectpb 113
dc.subjectplant extract
dc.subjectplant medicinal product
dc.subjectprotopine
dc.subjectpyrimethamine
dc.subjectrheagenine
dc.subjectsibiricine
dc.subjectstylopine
dc.subjectunclassified drug
dc.subjectvancomycin
dc.subjectantibacterial activity
dc.subjectantifungal activity
dc.subjectantiinflammatory activity
dc.subjectantiprotozoal activity
dc.subjectarticle
dc.subjectBhutan
dc.subjectbiological activity
dc.subjectcontrolled study
dc.subjectCorydalis crispa
dc.subjectcytokine production
dc.subjectdrug isolation
dc.subjectdrug mechanism
dc.subjectdrug screening
dc.subjectdrug structure
dc.subjectenzyme inhibition
dc.subjectnonhuman
dc.subjectnuclear magnetic resonance
dc.subjectPapaveraceae
dc.subjectphytochemistry
dc.subjectPlasmodium falciparum
dc.subjectCorydalis
dc.subjectFumariaceae
dc.subjectPlasmodium falciparum
dc.titlePhytochemical and biological activity studies of the Bhutanese medicinal plant corydalis crispa
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationNatural Product Communications. Vol 7, No.5 (2012), p.575-580
dc.identifier.doi10.1177/1934578x1200700507
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.